72 related articles for article (PubMed ID: 9328630)
1. L-arginine--substrate for no synthesis--its beneficial effects in therapy of patients with peripheral arterial disease: comparison with placebo-preliminary results.
Slawinski M; Grodzinska L; Kostka-Trabka E; Bieron K; Goszcz A; Gryglewski RJ
Acta Physiol Hung; 1996; 84(4):457-8. PubMed ID: 9328630
[TBL] [Abstract][Full Text] [Related]
2. Treatment with L-arginine is likely to stimulate generation of nitric oxide in patients with peripheral arterial obstructive disease.
Gryglewski RJ; Grodzińska L; Kostka-Trabka E; Korbut R; Bieroón K; Goszcz A; Sławiński M
Wien Klin Wochenschr; 1996; 108(4):111-6. PubMed ID: 8867484
[TBL] [Abstract][Full Text] [Related]
3. [Influence of L-arginine on development of atherosclerosis: what is the therapeutically assured?].
Bode-Böger SM
Dtsch Med Wochenschr; 2005 Mar; 130(11):593-8. PubMed ID: 15761791
[TBL] [Abstract][Full Text] [Related]
4. L-arginine supplementation in peripheral arterial disease: no benefit and possible harm.
Wilson AM; Harada R; Nair N; Balasubramanian N; Cooke JP
Circulation; 2007 Jul; 116(2):188-95. PubMed ID: 17592080
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
Tousoulis D; Böger RH; Antoniades C; Siasos G; Stefanadi E; Stefanadis C
Nat Clin Pract Cardiovasc Med; 2007 May; 4(5):274-83. PubMed ID: 17457351
[TBL] [Abstract][Full Text] [Related]
6. L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
Böger RH
Curr Opin Clin Nutr Metab Care; 2008 Jan; 11(1):55-61. PubMed ID: 18090660
[TBL] [Abstract][Full Text] [Related]
7. Effects of a nitric oxide synthase inhibitor on pressor response to angiotensin II in conscious rats.
Maeda T; Yoshimura T; Ohshige A; Koyama H; Ito M; Okamura H
Artery; 1998; 23(1):1-9. PubMed ID: 10846613
[TBL] [Abstract][Full Text] [Related]
8. Effect of L-arginine on blood pressure in pregnancy-induced hypertension: a randomized placebo-controlled trial.
Neri I; Jasonni VM; Gori GF; Blasi I; Facchinetti F
J Matern Fetal Neonatal Med; 2006 May; 19(5):277-81. PubMed ID: 16753767
[TBL] [Abstract][Full Text] [Related]
9. L-Arginine-nitric oxide pathway-related metabolites in the aqueous humor of diabetic patients.
Hattenbach LO; Allers A; Klais C; Koch F; Hecker M
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):213-7. PubMed ID: 10634623
[TBL] [Abstract][Full Text] [Related]
10. The effects of sustained-release-L-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals.
Miller AL
Altern Med Rev; 2006 Mar; 11(1):23-9. PubMed ID: 16597191
[TBL] [Abstract][Full Text] [Related]
11. Effects of cerivastatin on forearm vascular responses, blood pressure responsiveness and ambulatory blood pressure in type 2 diabetic men.
Tran D; Lowy A; Howes JB; Howes LG
Diabetes Obes Metab; 2005 May; 7(3):273-81. PubMed ID: 15811145
[TBL] [Abstract][Full Text] [Related]
12. L-Arginine infusion increases glucose clearance during prolonged exercise in humans.
McConell GK; Huynh NN; Lee-Young RS; Canny BJ; Wadley GD
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E60-E66. PubMed ID: 16105862
[TBL] [Abstract][Full Text] [Related]
13. Evidence for superoxide anion generation in aortas of cholesterol-fed rabbits treated with L-arginine.
Simonet S; Rupin A; Badier-Commander C; Coumailleau S; Behr-Roussel D; Verbeuren TJ
Eur J Pharmacol; 2004 May; 492(2-3):211-6. PubMed ID: 15178367
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of L-arginine supplementation in experimental hyperlipemia-hyperglycemia in the hamster.
Popov D; Costache G; Georgescu A; Enache M
Cell Tissue Res; 2002 Apr; 308(1):109-20. PubMed ID: 12012211
[TBL] [Abstract][Full Text] [Related]
15. [Effect of the acetylosalicyd acid (ASA) and ticlopidine therapy on clinical condition and parameters of blood platelets in patients with peripheral arterial occlusive disease (PAOD)].
Leo W; Westrych R; Bissinger A; Okraszewski J; Baj Z
Pol Merkur Lekarski; 2007 Nov; 23(137):335-9. PubMed ID: 18361314
[TBL] [Abstract][Full Text] [Related]
16. Optimizing nitric oxide production by time dependent L-arginine administration in isolated human corpus cavernosum.
Gur S; Kadowitz PJ; Trost L; Hellstrom WJ
J Urol; 2007 Oct; 178(4 Pt 1):1543-8. PubMed ID: 17707054
[TBL] [Abstract][Full Text] [Related]
17. Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway.
Shen LJ; Beloussow K; Shen WC
Biochem Pharmacol; 2005 Jan; 69(1):97-104. PubMed ID: 15588718
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute L-arginine infusion on non-stress test in hypertensive pregnant women.
Neri I; Blasi I; Facchinetti F
J Matern Fetal Neonatal Med; 2004 Jul; 16(1):23-6. PubMed ID: 15370078
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide modulation of blood vessel tone identified by arterial waveform analysis.
McVeigh GE; Allen PB; Morgan DR; Hanratty CG; Silke B
Clin Sci (Lond); 2001 Apr; 100(4):387-93. PubMed ID: 11256976
[TBL] [Abstract][Full Text] [Related]
20. The influence of two different doses of L-arginine oral supplementation on nitric oxide (NO) concentration and total antioxidant status (TAS) in atherosclerotic patients.
Jabłecka A; Checiński P; Krauss H; Micker M; Ast J
Med Sci Monit; 2004 Jan; 10(1):CR29-32. PubMed ID: 14704633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
